Research & Development
Collaboration: Page 2
Mission Bio, Abiosciences announce collaboration on hematologic cancer research applications
They aim to combine Mission Bio’s multiomics and single-cell DNA capabilities with Abiosciences’ AI technology in finding disease signatures, identifying and addressing mechanisms of therapeutic resistance, and stratifying patients for clinical trials.
December 28, 2022
NewStem to collaborate with MSK Innovation Hub on oncology software
The collaboration will focus on the use of NewStem’s Software Diagnostic Device bioinformatics software for triple-negative breast cancer patients and non-small cell lung cancer patients treated with paclitaxel and/or carboplatin.
December 14, 2022
PreciseDx, Dordrecht Albert Schweitzer Hospital to evaluate cancer risk stratification platform
The Laboratory of Pathology at Dordrecht, in the Netherlands, will study the performance of PreciseDx's artificial intelligence-based cancer risk stratification platform and test.
November 29, 2022
BARDA to support algorithm and app development for infectious disease detection
Support for algorithm and app development is part of BARDA’s new Digital Medical Countermeasures program aimed at developing digital tools to enable faster, more accessible approaches during public health emergencies.
November 9, 2022
Mayo Clinic, Numares Health expand collaboration, develop AI-enabled diagnostic testing for chronic disease
Expanding upon Mayo Clinic’s clinical research support for Numares Health, the collaboration will focus on researching and developing AI-enabled diagnostic testing solutions.
November 3, 2022
Genomenon publishes ENPP1 deficiency database
The data are available to doctors, researchers, and clinicians through Mastermind, and the findings will shed light on the deficiency and possible treatment approaches, the firm said.
November 1, 2022
Deepcell expands adoption of AI-enabled morphology characterization for biological researchers
The University of California, San Francisco and the Translational Genomics Research Institute are the initial locations to have the first generation of the Deepcell platform installed through a Technology Access Program.
November 1, 2022
Oxford Nanopore, 10x Genomics collaborate to enable a streamlined workflow for sequencing full-length transcripts in single reads
The collaboration will integrate Oxford’s PromethION devices and other flow cells and kits with 10x Genomics’ Compatible Partner Program, allowing for more streamlined workflow.
October 27, 2022
Sema4, MGH collaborate to compare genome and exome sequencing with multi-gene panels
In the study, genomic tests reported 30% fewer inconclusive results compared to multi-gene panel tests (23% vs. 33%) and a higher diagnostic yield (18% vs. 10%)
October 26, 2022
MDIC partners with PerkinElmer's Horizon Discovery on somatic reference samples
The SRSs are expected to be commercially available through Horizon Discovery by early 2024; the characterization data will be available in publicly accessible databases.
October 20, 2022
PacBio partners with Broad Institute, 10x Genomics to launch single-cell RNA sequencing kit
The kit will help single-cell researchers better identify and characterize novel isoforms, novel driver mutations, and cancer fusion genes for research into cancers and neurodegenerative diseases.
October 20, 2022
PacBio, Twist Bioscience collaborate to launch long-read gene panels for research
One panel covers nearly 400 challenging genes associated with spinal muscular atrophy, Alzheimer’s, cardiovascular disease, and other diseases.
October 19, 2022
Page 2 of 5